• PCR112 Characteristics of Individuals Living with Obesity in Germany, Weight-Loss Methods Attempted and Healthcare Resource Use over a 12-Month Period

    Dec 1, 2023, 00:00

  • EE323 Cost Comparison Analysis of Patiromer Versus Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in Saudi Arabia

    Dec 1, 2023, 00:00

  • HSD73 Establishing a Learning Healthcare System for Metastatic Prostate Cancer in the Dutch Healthcare System: Preconditions and Potential Benefits of Real-World Data Utilization

    Dec 1, 2023, 00:00

  • HTA26 Portuguese Clinical Practice and Costs in the Treatment of Acid Sphingomyelinase Deficiency Disease

    Dec 1, 2023, 00:00

  • SA44 Clinical Burden of Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Focused Literature Review

    Dec 1, 2023, 00:00

  • HPR93 Impact of Generic Competition on Prices, Public Spending and Utilization of Antiepileptic Medicines in Bulgaria

    Dec 1, 2023, 00:00

  • HSD45 Atopic Dermatitis’ Treatment Patterns in Latin America: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE50 What Is the Economic Impact of an Early Adoption of High Efficacy Treatments in Multiple Sclerosis? A Cost-Consequence Analysis From a Societal Perspective in the Portuguese Setting

    Dec 1, 2023, 00:00

  • MT79 This Technology Should be Compared With? And Who for? The Digital Health Population Conundrum

    Dec 1, 2023, 00:00

  • EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study

    Dec 1, 2023, 00:00

  • EPH88 Human Papillomavirus (HPV) Vaccination Coverage Among French Adolescents: Papillon Study

    Dec 1, 2023, 00:00

  • EE203 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Other First-Line Therapies for Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer in the United States

    Dec 1, 2023, 00:00

  • CO140 Drivers of Physicians’ Treatment Decision-Making and Future Treatment Expectations: Analysis of the Adelphi Real-World Ovarian Cancer II Disease Specific Programme (DSPTM)

    Dec 1, 2023, 00:00

  • HTA291 How Are Patients Involved in Health Technology Assessment? A Comparative Analysis of European Markets for Advanced Therapies and Implications for Joint Clinical Assessment

    Dec 1, 2023, 00:00

  • HTA230 Comparative Evaluation of the Performance of Two Value Attribution Frameworks When Applied to Combination Regimens in Oncology

    Dec 1, 2023, 00:00

  • EE661 The Quality of Economic Evaluations of Breast Cancer for Diagnostics, Screening, and Therapeutics in the Middle East: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • RWD110 Lifetime Costs of Stroke in Brazil with a Focus on Hemorrhagic Subtypes

    Dec 1, 2023, 00:00

  • EE125 Cost Consequences of Using Clevidipine in Acute Hypertension from the Perspective of a US Hospital

    Dec 1, 2023, 00:00

  • HPR41 Linking the Price of a Drug to Its Real-Life Performan A Solution for Financing Innovative Therapies in France?

    Dec 1, 2023, 00:00

  • PT46 Does Public Research Investment on Emerging Infectious Diseases Correspond to Disease Burden in China? A Cross-Sectional Study from 2009 to 2019

    Dec 1, 2023, 00:00

  • EPH208 Adoption of Precision Health (PH) and Precision Medicine (PM) Approaches in Addressing Population Health Needs in Europe

    Dec 1, 2023, 00:00

  • CO49 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Ixekizumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis

    Dec 1, 2023, 00:00

  • P19 Demographics of Patients and Societal Burden of Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Italy and Spain

    Dec 1, 2023, 00:00

  • EPH39 Epidemiology and Patient Characteristics of Pemphigus Vulgaris in Italy Based on Administrative Database

    Dec 1, 2023, 00:00

  • HTA336 The Danish Health Technology Council – HTA Organisations As the Nexus between Science and Policy

    Dec 1, 2023, 00:00

  • RWD181 Improving Clinical Practice and Patient-Centric Care through Digital Outcome Measurement Tools

    Dec 1, 2023, 00:00

  • EE234 Economic Analysis of the Pronto Study

    Dec 1, 2023, 00:00

  • EE624 The Economic Burden of Macrovascular Complications of Diabetes in Algeria

    Dec 1, 2023, 00:00

  • EPH54 What Do the Students Think About Food Safety Knowledge at the University of Pécs?

    Dec 1, 2023, 00:00

  • HPR102 Factors Influencing Orphan Drug Net Prices in the EU4 and US – Insights from Payers

    Dec 1, 2023, 00:00

  • HTA197 Increasing Patient Access in Scandinavia Through Outcome Based Agreements: Can the Spanish Model be Replicated?

    Dec 1, 2023, 00:00

  • EPH47 Modeling the Impact of the Vaccine Candidate TAK-003 on the Incidence of Dengue in French Overseas Territories

    Dec 1, 2023, 00:00

  • EPH11 Prevalence, Risk Factors, and Characterization of Individuals with Long COVID Using Electronic Health Records in Over 1.5 Million COVID Cases in England

    Dec 1, 2023, 00:00

  • EE749 Cost-Effectiveness Analysis of the Pediatric 20-Valent Pneumococcal Conjugate Vaccine Compared to Lower-Valent Alternatives in Argentina

    Dec 1, 2023, 00:00

  • P26 Drug Utilization, Adherence, and Persistence in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada

    Dec 1, 2023, 00:00

  • PCR23 Patient Preferences for Treatment Attributes and Endpoints in Neoadjuvant Therapy for Early-Stage Breast Cancer

    Dec 1, 2023, 00:00

  • PT25 Comparison of Approval Dates of New Substances Between the United States of America (Food and Drug Administration, FDA) and Europe (European Medicines Agency, EMA)

    Dec 1, 2023, 00:00

  • EE59 Real-Life Costs of Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated by CAR T-Cells in France Between 2017 and 2020 (EpiCART Study)

    Dec 1, 2023, 00:00

  • HTA314 A Review of Pediatric Medicines Assessed by NICE Between 2018 and 2023

    Dec 1, 2023, 00:00

  • OP3 Single-Use Vs Reusable Endoscopy Reprocessing: An Efficiency Survey of Nurses and Technicians

    Dec 1, 2023, 00:00

  • EPH96 Projected Prevalence of Acute, Chronic, and End-Stage Kidney Disease in the UK From 2023 to 2033

    Dec 1, 2023, 00:00

  • HTA212 Level of ICER of Health Economic Assessment in France in 2022

    Dec 1, 2023, 00:00

  • CO10 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Psoriatic Arthritis

    Dec 1, 2023, 00:00

  • HPR122 A Conceptual Modeling Framework for Manufacturers to Navigate the Inflation Reduction Act and to Negotiate a “Fair Maximum Price”

    Dec 1, 2023, 00:00

  • CO63 Systematic Literature Review of Health-Related Quality of Life in Advanced or Metastatic Esophageal Cancer

    Dec 1, 2023, 00:00

  • CO169 Pan-Stakeholder Core Outcome Set (COS) Definition for Hematological Malignancies in the Framework of the EU Project, Harmony: the Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology

    Dec 1, 2023, 00:00

  • HPR216 Multi-Stakeholder Perspectives on Interpretation, Challenges, and Ways Forward for the Unmet Medical Need Concept – Semi-Structured Interviews

    Dec 1, 2023, 00:00

  • HTA151 Subjective Well-Being and Mental Health During the COVID-19 Pandemic in Hungary

    Dec 1, 2023, 00:00

  • EE585 Threshold Price Analysis of Micro-Hole Zone Technology Catheters Compared to Standard Hydrophilic-Coated Catheters in Long-Term Intermittent Catheter Users in the UK

    Dec 1, 2023, 00:00

  • RWD164 The Impact of Spinal Muscular Atrophy (SMA) Type 1 on Caregivers in Taiwan: Results of a Global Survey

    Dec 1, 2023, 00:00

  • EE249 Cost and Outcomes of Teduglutide in Adult Patients With Short Bowel Syndrome—Is the Combination With BSC Cost-Effective for the Society?

    Dec 1, 2023, 00:00

  • EE219 Lorlatinib as a First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Greece

    Dec 1, 2023, 00:00

  • MSR69 Modelling Social and Economic Burden of Hepatits C in Russia in Different Scenarios of Control Measures up to 2035

    Dec 1, 2023, 00:00

  • MSR41 Machine Learning and Patient-Reported Outcomes (PROs) in Oncology: A Systematic Literature Review on Methodological Quality

    Dec 1, 2023, 00:00

  • MT24 Digital Therapeutics (DTX): Market Access Challenges and Stakeholder Perspectives in Germany

    Dec 1, 2023, 00:00

  • CO14 Identification Use of Prognostic Variables (PVs)/Treatment Effect Modifiers (TEMs) in Indirect Treatment Comparisons (ITCs) By Systematic Literature Review (SLR): Case Study of Chimeric Antigen Receptor (CAR) T-Cell Therapies

    Dec 1, 2023, 00:00

  • HTA80 To What Extent Do the EUnetHTA 21 D4.4 Guidelines on Endpoints Recognize Non-Os Endpoints and Patient-Reported Outcomes, and What Opportunities Exist in the Joint Clinical Assessment to Reflect Their Value?

    Dec 1, 2023, 00:00

  • HTA366 NICE Technology Appraisals Based on Single-Arm Trials in 2022 – What Can We Learn from Them?

    Dec 1, 2023, 00:00

  • EPH256 Healthcare Resource Utilization and Related Cost Among Patients Hospitalized for Prurigo Nodularis: A Retrospective Cohort Study Using Italian Health Claims Data

    Dec 1, 2023, 00:00

  • EE258 Healthcare Resource Utilization and Economic Burden of Hidradenitis Suppurativa in German Patients with Hidradenitis Suppurativa

    Dec 1, 2023, 00:00

  • EE401 A Comparison of Health State Occupancy Between Cipaglucosidase Alfa/Miglustat and Alglucosidase Alfa Within a Cost-Effectiveness Modelling Analysis of Late-Onset Pompe Disease

    Dec 1, 2023, 00:00

  • MT3 Intracardiac Echocardiography Operational Experience of Chinese Interventional Cardiologists in Conducting Radio-Frequency Catheter Ablation for Cardiac Arrhythmias: A Cross-Sectional Survey Study

    Dec 1, 2023, 00:00

  • PCR80 Patient Preferences for Stages II/III and Stage IV Melanoma Treatments in the UK

    Dec 1, 2023, 00:00

  • MSR64 How Is Machine Learning Being Used in HEOR? A Systematic Review of Trends and Methods

    Dec 1, 2023, 00:00

  • PCR75 Real-World Evidence of Outcomes of Fulvestrant Monotherapy After Progression on CDK4/6 Inhibitor + Aromatase Inhibitor in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

    Dec 1, 2023, 00:00

  • MSR42 A Parametric Method for Unanchored Matching-Adjusted Indirect Treatment Comparison (MAIC) Based on Survival Outcomes for Health Economic (HE) Models in Absence of Proportional Hazards (PH)

    Dec 1, 2023, 00:00

  • MSR66 Natural Language Processing to Support the Abstract Selection During Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE416 The Cost-Effectiveness of WaveWriter Alpha Spinal Cord Stimulation System in a Swedish Setting

    Dec 1, 2023, 00:00

  • HSD61 The Diagnostic Journey of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia, and the Importance of Biomarker Testing for Timely Diagnosis: A Real-World Survey in Europe

    Dec 1, 2023, 00:00

  • HSD117 Healthcare Resources Utilization (HCRU) and Exploration of the Patient Journey through Claims Database: An Application on Advanced Renal Cell Carcinoma (ARCC) Patients in France

    Dec 1, 2023, 00:00

  • EE25 Cost-Effectiveness Analysis of S-Adenosylmethionine for the Treatment of Intrahepatic Cholestasis in China

    Dec 1, 2023, 00:00

  • MSR84 Summarizing Adverse Event Data in the Absence of High-Level Eviden The Case of Hearing Implants

    Dec 1, 2023, 00:00

  • PCR117 A Qualitative Interview Study into the Experiences of Fatigue and Depression in Chronic Hepatitis B

    Dec 1, 2023, 00:00

  • EE615 A Cost-Effectiveness Analysis of the CNIC-Polypill Strategy, Compared to Usual Care, in Secondary Cardiovascular Prevention from a Spanish Perspective Using Data from the Secure Trial

    Dec 1, 2023, 00:00

  • EE259 The Societal Cost of Age-Related Macular Degeneration and Diabetic Macular Edema: An Estimation Using a Pragmatic Literature Review

    Dec 1, 2023, 00:00

  • EE283 Value of Information Analyses for Advanced Cell Therapies: A Systematic Review

    Dec 1, 2023, 00:00

  • CO69 Evidence Gap Analysis of the Burden of Illness and Treatment of Bullous Pemphigoid

    Dec 1, 2023, 00:00

  • HPR63 Plasma Last Liter Economics and Its Impact on the Costs of Major Human Polyvalent Immunoglobulins in Europe

    Dec 1, 2023, 00:00

  • EE344 Cost per Responder Associated with Bimekizumab Against Il-17A-Inhibitors in the Treatment of Axial Spondyloarthritis in Sweden

    Dec 1, 2023, 00:00

  • HTA136 Analysis of the Reimbursement and Pricing of Hybrid Medicines in France

    Dec 1, 2023, 00:00

  • HTA22 Access to Orphan Pediatric and Adolescent Medicinal Products in Greece Over 4 Years (2018-2021)

    Dec 1, 2023, 00:00

  • MT28 Physician Experiences and Preferences in Peripheral Bronchoscopy for Diagnosing Patients with Solitary Pulmonary Nodules Suspected of Lung Cancer: A Multi-Country, Cross-Sectional Survey

    Dec 1, 2023, 00:00

  • EE149 Surge Capacity for Preserving Accessibility to Primary Healthcare Services during the COVID19 Pandemic in a Middle Income Country

    Dec 1, 2023, 00:00

  • CO144 A Trial-Based Health Utility Analysis in Patients with Acanthamoeba Keratitis

    Dec 1, 2023, 00:00

  • SA6 Cost-of-Illness of Skin Cancer: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE588 The Budget Impact of Introducing Robotic-Assisted Surgery for Spinal Fusion Procedures in Spain

    Dec 1, 2023, 00:00

  • HSD118 Patient Safety in Oncology: Quantifying the Hospital-Associated Risks with a Discrete-Events Simulation

    Dec 1, 2023, 00:00

  • HTA207 Can We Speak to GPT to Inform Health Technology Assessments?

    Dec 1, 2023, 00:00

  • HPR116 Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation

    Dec 1, 2023, 00:00

  • HPR219 "Direct Access" Experiment in Fran Potential Impact on the Pricing of Innovative Medicines

    Dec 1, 2023, 00:00

  • SA41 Novel Method for Indirect Comparison of Treatment Sequences Using Averaged Parametric Survival Models with Application to Hepatocellular Carcinoma

    Dec 1, 2023, 00:00

  • HTA108 Willingness-to-Pay for Orphan Drugs – ICER Thresholds Approved by TLV in Sweden

    Dec 1, 2023, 00:00

  • HSD113 Access to Medicines, Care, and Services for Multiple Sclerosis Patients in Central and Eastern European Countries: A Comparative Analysis

    Dec 1, 2023, 00:00

  • PCR115 Health-Related Quality of Life Associated With Common Stoma Complications—Peristomal Skin Complications and Leakages Onto Clothes

    Dec 1, 2023, 00:00

  • PCR114 The Association Between Health-Related Quality of Life and Social Determinants of Health for Diabetes in Japan: A Cross-Sectional Patient Survey

    Dec 1, 2023, 00:00

  • CO43 Projecting Cardiovascular Benefits Associated With Tirzepatide's Effects on Cardiovascular Risk Factors in Patients With Type 2 Diabetes in Fran A Simulation Study

    Dec 1, 2023, 00:00

  • HSD12 Hepatocellular Carcinoma Patient Pathway in Portugal – From Diagnosis to Treatment – Results From Opal Study

    Dec 1, 2023, 00:00

  • EE607 Development of an Online Database of Published Usable Mapping Algorithms Used to Estimate EQ-5D Utilities

    Dec 1, 2023, 00:00

  • EE187 Use of Resources and Economic Cost of People Living with HIV in the Brazilian Supplementary Health System

    Dec 1, 2023, 00:00

  • HPR33 Follow the Money: Reporting Public Contributions and Incentives on Research and Development Programs for Agenzia Italiana Del Farmaco (AIFA; ITALIAN MEDICINES AGENCY)

    Dec 1, 2023, 00:00

  • EE237 The Budget Impact of Introducing Automated Hematoxylin and Eosin Staining for Cancer Diagnosis in China

    Dec 1, 2023, 00:00

  • HSD109 What Are the Main Challenges in Management Care of Stoma Patients in Fran Guidelines from Shield Multidisciplinary Experts for Optimization

    Dec 1, 2023, 00:00

  • EE127 CAR-T Cell Therapies' Pathway: Evolution of Management and of Costing Methodology in the French Cost-Effectiveness Analyses (CEA) Landscape

    Dec 1, 2023, 00:00

  • CO26 Efficacy of the Dupilumab 200 Mg Dose Every 2 Weeks in Children with Moderate-to-Severe Asthma during Voyage and Excursion

    Dec 1, 2023, 00:00

  • SA57 Unmet Needs and Evidence Gaps in Relapsed/Refractory Marginal Zone Lymphoma: Findings from a Systematic Literature Review

    Dec 1, 2023, 00:00

  • CO45 A Systematic Review of Quality of Life and Gastroesophageal Reflux Disease

    Dec 1, 2023, 00:00

  • EE671 Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment for Renal Cell Carcinoma Post-Nephrectomy in France

    Dec 1, 2023, 00:00

  • PT7 Data Standardization in Brazil: An OMOP Common Data Model Approach in a DATASUS Cohort

    Dec 1, 2023, 00:00

  • EE433 Cost and Duration of Hospital Stays for Complex Patients Receiving a Micra or a Conventional Pacemaker With Epicardial Leads in France

    Dec 1, 2023, 00:00

  • HPR71 All Back to Square One: What Follows from the New Algorithm for Drug Pricing in Germany?

    Dec 1, 2023, 00:00

  • PCR6 Impact of Perianal Fistulas on Crohn’s Disease Patients

    Dec 1, 2023, 00:00

  • EE590 Assessing Health Outcomes and Cost-Effectiveness of Adult HPV Vaccination in Italy

    Dec 1, 2023, 00:00

  • EE223 Estimation of the T-Cell Engagers (Bi-Specific Monoclonal Antibodies and Chimeric Antigen Receptor [CAR T-CELL]) Therapy Administration Pathways From French Hospitals and National Health Insurance Perspective and Financial Impact

    Dec 1, 2023, 00:00

  • RWD56 Real World Data for Planning a New Organised Cancer Screening Programme in the Czech Republic: Example of Prostate Cancer Screening

    Dec 1, 2023, 00:00

  • EE319 Update to the Macrovascular Submodels of the IQVIA Core Diabetes Model

    Dec 1, 2023, 00:00

  • OP21 A Validated Dutch Translation of the CHEERS II Statement

    Dec 1, 2023, 00:00

  • EE85 Health System Costs and Resources for Stage-Specific Breast Cancer: A Population-Based Approach (Updated)

    Dec 1, 2023, 00:00

  • HPR78 From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada

    Dec 1, 2023, 00:00

  • EE510 Downstaging Pancreatic Cancer is Cost-Effective: Can We Achieve a Cost-Effective Early Diagnosis?

    Dec 1, 2023, 00:00

  • PCR110 Translation and Cultural Adaptation of Clinical Outcome Assessments (COAs)—Is Machine Translation a Viable Option?

    Dec 1, 2023, 00:00

  • HTA284 Early Access in Fran Descriptive Analysis of Eap Decisions Two Years after the Reform

    Dec 1, 2023, 00:00

  • HTA77 Is Stedi Steady? an Exploration of the Uncertainties Underlying the Quantification of the Broader Value of Antibiotics

    Dec 1, 2023, 00:00

  • EPH12 Estimating the Prevalence of Hepatitis Delta in the UK: A Migration Model Approach Applied in Practice

    Dec 1, 2023, 00:00

  • EE222 Cost Minimization Analysis of Damoctocog Alfa Pegol in the Treatment of Severe Hemophilia A Patients in Mexico

    Dec 1, 2023, 00:00

  • EE429 Current Parallel Trade Practice in the Pharmaceutical Industry Focusing on European Single Market, Utilizing a Cost-Saving Analysis in the Allergen Immunotherapy Market of Germany

    Dec 1, 2023, 00:00

  • RWD85 A Systematic Literature Review on the Use of Real-World Evidence in NICE Technology Appraisals Indicated for Multiple Myeloma

    Dec 1, 2023, 00:00

  • HSD18 Itch Intensity and Therapeutic Management of Pruritus in the Real-World Setting

    Dec 1, 2023, 00:00

  • EPH227 Clinical, Economic, and Patient-Reported Impact of Obesity in Selected European Countries: A Systematic Review

    Dec 1, 2023, 00:00

  • PCR208 Pace CKD Financial Burden and Work Productivity Assessment of Chronic Kidney Disease on Patients: Results from an International Survey

    Dec 1, 2023, 00:00

  • EE747 Cost-Utility Analysis of 15-Valent Pneumococcal Conjugate Vaccine in the Immunization of Adults Over 65 Years of Age in the Czech Republic

    Dec 1, 2023, 00:00

  • EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer

    Dec 1, 2023, 00:00

  • EE593 Cost-Effectiveness Model of COVID-19 Vaccination: The United Kingdom Perspective

    Dec 1, 2023, 00:00

  • HTA251 Unraveling the Relationship between Expedited Regulatory Approval By the European Medicines Agency (EMA) and Reimbursement Outcomes for Drugs Approved Under Exceptional Circumstances

    Dec 1, 2023, 00:00

  • HTA294 Using Machine Learning to Predict HTA Approval: Importance of Patient Subgroup Specification Within Obesity

    Dec 1, 2023, 00:00

  • PT41 Real-World Evidence in Rare Diseases in Fran Treatment Patterns, Healthcare Resource Use, and Related Costs in Von Willebrand Disease (FORvWARD Study)

    Dec 1, 2023, 00:00

  • PCR222 Safety and Quality of Life of Various Artificial Pancreas Systems in Patients With Type 1 Diabetes Mellitus: A Systematic Review of Real-World Evidence

    Dec 1, 2023, 00:00

  • MSR149 Cost-Effectiveness Model Conceptualisation in Chronic Graft Versus Host Disease

    Dec 1, 2023, 00:00

  • Section 50 of the Inflation Reduction Act Drug Price Negotiation Program: Considerations for the Centers for Medicare Medicaid Services, Manufacturers, and the Health Economics and Outcomes Research Community [Editor's Choice]

    Dec 1, 2023, 00:00

  • RWD104 Shifting Tides: Unveiling the Burden of Demographic Change in Germany Through Administrative Hospital Data

    Dec 1, 2023, 00:00

  • HSD49 Impact of Endoscope Choice on Nurse Time in GI Surgical Procedures: A Prospective Study in a Danish University Hospital

    Dec 1, 2023, 00:00

  • EPH107 Predictors and Consequences of Pediatric Nurses' Burnout: An Integrative Review

    Dec 1, 2023, 00:00

  • MSR56 Incorporating Background Mortality Into Survival Extrapolations: Determining the Accuracy Using a Simulation Study

    Dec 1, 2023, 00:00

  • EE407 Economic Assessment in Resource-Constrained Systems – a Case Study Using an Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema

    Dec 1, 2023, 00:00

  • EPH94 Comparative Analysis of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus: A Nationwide US Medicare Perspective

    Dec 1, 2023, 00:00

  • EE96 Resource Consumption Analysis in Patients with Hemophilia A Without Inhibitors on Prophylaxis with FVIII Before Switching to Emicizumab

    Dec 1, 2023, 00:00

  • HTA347 Exploration of the Factors Driving Decisions of the Transparency Commission Based on an Analysis of HAS Meeting Transcripts Using Natural Language Processing

    Dec 1, 2023, 00:00

  • HPR66 Assessing the Impact and Strategic Implications of the HTA Regulation 2021/20282 on National Processes: A Scoping Review and Stakeholders Perspectives Through Semi-Structured Interviews

    Dec 1, 2023, 00:00

  • SA65 Trends in the Systematic Literature Reviews Over the Years

    Dec 1, 2023, 00:00

  • EPH7 Estimating the Projected Impact of Weight Loss on Obesity Prevalence and Healthcare Costs in a UK Population

    Dec 1, 2023, 00:00

  • HSD112 Real-World Trends in APOE Genetic Testing Associated with Lecanemab

    Dec 1, 2023, 00:00

  • EE130 Impact of Phacoemulsification Equipment in Surgical Throughput, Under the Perspective of a Greek Hospital

    Dec 1, 2023, 00:00

  • PCR159 Considerations for Maximizing the Research Value of PRO Data Collected in Clinical Care

    Dec 1, 2023, 00:00

  • MSR63 Implementing Simple Active Learning (AL) Boosters Considerably Improves the Early Identification of Relevant Studies in the Systematic Literature Review (SLR) Process

    Dec 1, 2023, 00:00

  • RWD40 Assessing the Representativeness of Body Mass Index Categories Across Multiple Types of Secondary Data Sources

    Dec 1, 2023, 00:00

  • PCR140 Management of Osteogenesis Imperfecta: Self-Reported Access Challenges to Consumables and Services Across the EU5 and Nordics

    Dec 1, 2023, 00:00

  • HTA166 Cost-Effectiveness of Combination Pertuzumab+Trastuzumab Vs Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer (HER2+ eBC) in the Czech Republic

    Dec 1, 2023, 00:00

  • EE190 How Many Patients Diagnosed with Mild Cognitive Impairment Are Willing to Pay for a PET Scan to Receive the Treatment for Alzheimer′S Disease in Japan?

    Dec 1, 2023, 00:00

  • HTA107 Are All Unmet Needs Valued the Same? A Review of Disease Prioritization and Related Resource Allocation in Europe

    Dec 1, 2023, 00:00

  • EPH109 Predictors of Individual General Life Satisfaction in the German General Social Survey (ALLBUS) Cohorts from 2010 to 2021

    Dec 1, 2023, 00:00

  • EE210 Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy as Neoadjuvant Therapy and Continued as a Single Agent as Adjuvant Therapy for High-Risk Early-Stage Triple-Negative Breast Cancer in Greece

    Dec 1, 2023, 00:00

  • HTA292 Implications of EU HTA on Future Relevance of Surrogate Outcomes in National Assessment

    Dec 1, 2023, 00:00

  • EE339 Use of Dalbavancin in the Treatment of Pediatric Acute Bacterial Skin and Skin Structure Infections in the Spanish Hospital Setting: A Comparative Cost Analysis

    Dec 1, 2023, 00:00

  • HSD17 Key Features and Preferences for New High-Volume Low-Complexity Outpatient Care: Using Discrete Choice Experiments in Ophthalmology to Improve Diagnostic Service Delivery in England

    Dec 1, 2023, 00:00

  • P39 Machine Learning to Identify Atopic Dermatitis Prevalence Using Healthcare Utilisation Patterns of Both Diagnosed and Non-Diagnosed AD Patients Based on Danish Register Data

    Dec 1, 2023, 00:00

  • HTA145 Similarity of Guidelines for Direct and Indirect Comparisons Under Eunethta and Country-Specific HTA – Implications for Supportive Agents

    Dec 1, 2023, 00:00

  • HPR3 Burden of HIV/AIDS Assessment and Forecast for 2030 in Turkiye

    Dec 1, 2023, 00:00

  • RWD62 Dupixam: An SNDS (SYSTÈME NATIONAL DES DONNÉES DE SANTÉ) Study to Characterize Patients Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis in France

    Dec 1, 2023, 00:00

  • RWD48 Identification and Assessment of Real-World Oncology Data in China: A Data Landscaping Study

    Dec 1, 2023, 00:00

  • EE311 Starts with Sacubitril/Valsartan in the Inpatient Vs Outpatient Setting in Spain

    Dec 1, 2023, 00:00

  • RWD180 Analyzing Medical Patterns and Catastrophic Health Expenses in Occupational Injuries Victims in South Korea

    Dec 1, 2023, 00:00

  • EE38 Cost-Effectiveness Analysis of the NEON Intervention for People With Psychosis and Non-Psychosis Mental Health Problems

    Dec 1, 2023, 00:00

  • MT67 The Effectiveness of Body Composition Analysis Using Dual-Energy X-Ray Absorptiometry (DEXA) for Diagnosing Sarcopenia: Literature Review

    Dec 1, 2023, 00:00

  • EE532 A Conceptual Model for the Cost Effectiveness of Artificial Intelligence-Assisted Chest Computed Tomography (CT) to Detect Lung Nodules and Improve Decision Making

    Dec 1, 2023, 00:00

  • PT20 Applications for Tolvaptan (JINARC®) Under a Managed Access Protocol in Ireland

    Dec 1, 2023, 00:00

  • EE654 Occupational Impact of Tardive Dyskinesia: A Cross-Sectional, International Survey Assessing the Perceptions and Experiences of Patients With TD and Physicians Who Treat TD

    Dec 1, 2023, 00:00

  • HTA19 Insights Into NICE Technology Appraisal Outcomes in Oncology

    Dec 1, 2023, 00:00

  • MSR92 Can Artificial Intelligence (AI) Large Language Models (LLMS) Such as Generative Pre-Trained Transformer (GPT) Be Used to Automate Literature Reviews?

    Dec 1, 2023, 00:00

  • EE116 Quantifying the Future Impact of Chronic Kidney Disease Screening Programs in Belgium

    Dec 1, 2023, 00:00

  • MT74 The Impact of Installing a Rfid Cabinet for the Inventory of Intraocular Lenses As Part of the Cataract Surgery Pathway: A Spanish Public Hospital Perspective

    Dec 1, 2023, 00:00

  • EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US

    Dec 1, 2023, 00:00

  • PCR274 Patient Data Use in Medical Research Vs Data Privacy: Perspective from Five Patient Association Representatives

    Dec 1, 2023, 00:00

  • HTA267 Is the BBC Truly Impartial When Reporting on NICE’s Activities?

    Dec 1, 2023, 00:00

  • PCR166 Regaining Activities of Daily Living After Stroke – What Matters Most for Patients in Neurorehabilitation?

    Dec 1, 2023, 00:00

  • EPH112 Prevalence, Incidence, and Patient Characteristics of Valvular Heart Disease Using the National Database of Health Insurance Claims in Japan

    Dec 1, 2023, 00:00

  • PCR266 Transplant Physicians’ Preferences in Deceased Organ Allocation: A Pilot Discrete Choice Experiment

    Dec 1, 2023, 00:00

  • EE263 Economic and Healthcare Burden of Blood Transfusions in Transfusion-Dependent Beta-Thalassemia in Thailand and Brazil

    Dec 1, 2023, 00:00

  • EE141 Budget Impact Model for the Swiss Healthcare System: Assessing Potential Budget Savings of an Adapted Fall-2023-COVID-19 Vaccination Strategy

    Dec 1, 2023, 00:00

  • EPH246 Landscape of Diffuse Large B-Cell Lymphoma (DLBCL) in Brazilian Public Healthcare System (SUS)

    Dec 1, 2023, 00:00

  • SA52 Clinical Impact of Using Digital Healthcare Technology to Manage Diabetes in Adolescents.: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • HTA281 Environmental Considerations in HTA: Can HTA Bodies Contribute to Environmental Sustainability?

    Dec 1, 2023, 00:00

  • HSD33 Horizontal Inequities in the Healthcare Expenditures for Communicable Disease: An Evidence from the National Sample Survey Data

    Dec 1, 2023, 00:00

  • EPH249 Effects of Adolescent MenACWY and MenC Vaccination in Germany: A Modelling Study

    Dec 1, 2023, 00:00

  • HPR18 How Will Recent Pricing Regulations Impact the Global Pricing Landscape?

    Dec 1, 2023, 00:00

  • EPH200 Healthcare Resource Consumption of Patients with Chronic Obstructive Pulmonary Disease Treated with Triple and Dual Therapy and Experiencing an Acute Exacerbation

    Dec 1, 2023, 00:00

  • RWD42 Stoma-Related Outcomes and Costs Associated with Initial Stoma Product Selection – Findings from a Swedish Register and Chart Review Study

    Dec 1, 2023, 00:00

  • PCR199 Value-Based Healthcare in Severe Asthma: Development of an Outcome Standard Set Pilot Study in Portugal

    Dec 1, 2023, 00:00

  • HPR80 Examination of the Changes in the Turkish Pharmaceutical Market between 2007 and 2021

    Dec 1, 2023, 00:00

  • EE655 Patients Level Cost of Treating Adverse Events in Alzheimer’s Disease for US-FDA Approved Treatments

    Dec 1, 2023, 00:00

  • SA66 Expert Elicitation Techniques: Informing Application in HTA Decision-Making

    Dec 1, 2023, 00:00

  • HSD24 Digital Medical Services Delivered by Internet Hospitals via WeChat in China: A Qualitative Analytical Research

    Dec 1, 2023, 00:00

  • EE753 Cost-Effectiveness Analysis of Fracture Prevention with 25-Hydroxyvitamin D (25(OH)D) Screening Among the Population over 65 Years Old in China

    Dec 1, 2023, 00:00

  • HTA91 5 Years of CAR-T Cell Therapies—Comparison of German AMNOG Dossiers in Terms of Available Evidence and Price Development

    Dec 1, 2023, 00:00

  • RWD37 Pre-/Post Prevalence of Cardiovascular Diseases in Hospitalized COVID Patients: A German Claims Data Analysis

    Dec 1, 2023, 00:00

  • EE144 Decision Modifiers Under Uncertainty: Comparison of Deterministic and Probabilistic Methods in Disease Severity Classification by NICE

    Dec 1, 2023, 00:00

  • SA71 Real-World Treatment Patterns for Acute Lymphoblastic Leukemia Utilizing Claims Data

    Dec 1, 2023, 00:00

  • EE748 Cost-Effectiveness Assessment of 20-Valent Pneumococcal Conjugate Vaccine in Hong Kong

    Dec 1, 2023, 00:00

  • EE529 Methodology for the Monetization of Vial Remnants in the Aseptic Unit

    Dec 1, 2023, 00:00

  • EE367 The Use of Genomic Tests for Early Breast Cancer in Finland Is Likely to be Cost-Effective at Common WTP Threshold

    Dec 1, 2023, 00:00

  • PT2 Comparing UK Value Sets and Mapping Functions for EQ-5D

    Dec 1, 2023, 00:00

  • EE509 Cost-Effectiveness of Multicancer Early Detection (MCED) With Preferential Detection of Clinically Aggressive Cancers

    Dec 1, 2023, 00:00

  • CO160 Burden of Illness and Treatment Patterns of Adult Patients with Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • RWD41 Utilization Patterns of Glucagon-like Peptide Receptor Agonists in Patients with Type 2 Diabetes in France and Italy

    Dec 1, 2023, 00:00

  • HTA37 Assessing the Definition and Outcomes of Innovative Drugs by Health Technology Assessment Bodies in England, France, and Italy (Q1 2023)

    Dec 1, 2023, 00:00

  • Copyright/Subscription

    Dec 1, 2023, 00:00

  • HTA20 Predicting Post-AMNOG Price for a New Product Launch in Germany

    Dec 1, 2023, 00:00

  • EE268 Healthcare Costs and All-Cause Mortality Following a Hyperkalemia Event and Reduction of RAASi Therapy in Sweden

    Dec 1, 2023, 00:00

  • PCR88 Use of Patient-Reported Outcomes for Sickle-Cell Disease in Clinical Trials – Do They Match with Consensus-Based Core Outcomes Sets Recommendations?

    Dec 1, 2023, 00:00

  • RWD52 A Machine Learning Model to Facilitate Patient-Level Risk Screening in Myelodysplastic Syndromes (MDS) Patients in Routine Clinical Practice

    Dec 1, 2023, 00:00

  • PCR192 Content Validity of the EQ-5D and Health Utilities Index (HUI) to Assess Health-Related Quality-of-Life (HRQoL) Impact in Duchenne Muscular Dystrophy (DMD)

    Dec 1, 2023, 00:00

  • PCR60 Shared Decision Making in Inflammatory Bowel Disease Clinical Practi What Are the Experiences, Barriers, and Opportunities According to Patients and Healthcare Professionals?

    Dec 1, 2023, 00:00

  • MSR118 Identifying Potential Long-COVID Patients Using Machine Learning: A German Claims Data Analysis

    Dec 1, 2023, 00:00

  • CO135 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Pharmaceutical Interventions for First-Line (1L) Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (MCRPC)

    Dec 1, 2023, 00:00

  • EE12 An Economic Model Comparing Fever Management to Fever Prevention With Advanced Targeted Temperature Management (ATTM) in Out-of-Hospital Cardiac Arrest (OHCA) Patients

    Dec 1, 2023, 00:00

  • EE754 Is the Paradigm Shifting? The REvalMED Pilot Program and Subsequent Integration of Economic Evaluations to Influence Pricing and Reimbursement Discussions in Spain

    Dec 1, 2023, 00:00

  • EE635 Medical Cost Trends for Diseases Associated with Bedridden Rural Residents in Japan

    Dec 1, 2023, 00:00

  • PCR146 Tuberculosis Patients’ Preferences for Improving Tuberculosis Care in Chitwan District, Nepal: A Discrete Choice Experiment

    Dec 1, 2023, 00:00

  • EE332 Evaluation of Hospital Pandemic Control Strategies of a Chinese Tertiary Care Hospital During the Late Phase of COVID-19 Pandemic

    Dec 1, 2023, 00:00

  • RWD57 Treatment Patterns and Cost of Care Among Patients With Metachromatic Leukodystrophy (MLD) in the US

    Dec 1, 2023, 00:00

  • CO109 A Targeted Review of Pharmacological Therapies for the Treatment of Chronic Spontaneous Urticaria

    Dec 1, 2023, 00:00

  • EPH162 A Retrospective Analysis of the Public Health Product Tax in Hungary, 2011-2022

    Dec 1, 2023, 00:00

  • EE400 Cost-Effectiveness of Cannabidiol (CBD) for the Treatment of Seizures in Patients with Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands

    Dec 1, 2023, 00:00

  • EE106 Artificial Intelligence (AI) Based Telemedicine for Cost-Effective Cataract Surgery Follow-up at NHS: An Economic Evaluation

    Dec 1, 2023, 00:00

  • HTA164 Implementing Combination Treatment Cost-Effectiveness Solutions Beyond the Legal Challenges – What Else Needs to be in Place?

    Dec 1, 2023, 00:00

  • PCR95 Healthcare Resource Utilization for Adults Diagnosed with Moderate to Severe Atopic Dermatitis in Greece (APOLO STUDY)

    Dec 1, 2023, 00:00

  • EE515 Economical Impact of Dose Reduction Treatment for Ribociclib, Palbociclib and Abemaciclib in Colombia

    Dec 1, 2023, 00:00

  • HTA23 Reasons for a Negative Pharmaceutical Benefits Advisory Committee (PBAC) Review in Rare Diseases in Australia: A Comprehensive Analysis

    Dec 1, 2023, 00:00

  • SA80 Priors on Between-Study Heterogeneity in Bayesian Meta-Analysis Models: A Simulation Study Using Hamiltonian Monte Carlo Sampling

    Dec 1, 2023, 00:00

  • HTA69 Health-Related Quality of Life in the German Early Benefit Assessment—An Update

    Dec 1, 2023, 00:00

  • EPH134 Prevalence of and Associated Factors for Therapy Delay Due to COVID-19 Pandemic Among Breast Cancer Patients in Europe

    Dec 1, 2023, 00:00

  • EE73 Ocean (OP-103): Patients with Relapsed/Refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone or Pomalidomide Plus Dexamethasone - a Resource Utilization Analysis of Adverse Events Leading to Hospitalizations

    Dec 1, 2023, 00:00

  • Faster Diagnosis and Treatment for Cancer: Assessing Patient Pathways Using a Panel Regression Analysis of the English National Cancer Registration Data [Editor's Choice]

    Dec 1, 2023, 00:00

  • HTA213 Undertaking Studies to Inform Public Policy: Managing Data Collection to Ensure Data Quality in the EQ-5D-5L UK Valuation Through the Use of Independent Quality Control Assessments

    Dec 1, 2023, 00:00

  • EE435 Cost-Analysis of a Machine Learning-Based Clinical Decision Support System to Guide Resilience-Strengthening Intervention Decisions in Breast Cancer Treatment: The Bounce Study

    Dec 1, 2023, 00:00

  • EE589 Use of Copulas for Correlated Sampling of Cost and Utility Parameters During Probabilistic Sensitivity Analysis for Cost-Effectiveness Analyses

    Dec 1, 2023, 00:00

  • HPR72 Regulation and Reality of the Market Access Process for Digital Health Applications (DiGA) in Germany

    Dec 1, 2023, 00:00

  • PCR252 Early Steps Towards a Huntington's Disease Burden-of-Illness Model: Estimating Out-of-Pocket Costs for Patients Showing Clinical Symptoms

    Dec 1, 2023, 00:00

  • RWD19 Risk of Death Before and After Metastasis in High-Risk Localized and Locally Advanced Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy as Primary Treatment in the United States: A Retrospective Study

    Dec 1, 2023, 00:00

  • EPH18 Incidence of Postpartum Mental and Behavioral Disorders in Japan

    Dec 1, 2023, 00:00

  • RWD176 Economic Results Generated By Optimizing a Parenteral Medication Application Process

    Dec 1, 2023, 00:00

  • RWD2 Catheter Ablation to Treat Cardiac Arrhythmia in Germany – Trends Based on German Hospital Data

    Dec 1, 2023, 00:00

  • RWD28 Healthcare Resource Utilization and Cost of Renal Replacement Therapy in Brazil: A Five-Year Patient-Level Analysis

    Dec 1, 2023, 00:00

  • EE157 The Societal Impact of Inclisiran Using Population Health Approaches Across 15 Countries

    Dec 1, 2023, 00:00

  • MT44 Submission Process and Requirements of Nordic Health Technology Assessment Organisations for Medical Technologies: Results of an Online Survey

    Dec 1, 2023, 00:00

  • EE682 Number Needed to Treat (NNT) Comparing Axicabtagene Ciloleucel and Best Supportive Care for Third Line Diffuse Large B-Cell Lymphoma in Brazil

    Dec 1, 2023, 00:00

  • P10 Impact of the COVID-19 Pandemic on Cancer Screenings in Portugal and Years of Life Lost Due to Delayed Diagnoses

    Dec 1, 2023, 00:00

  • EE252 The Economic Implication of Sinus Rapid Relief Pathway in Italy: Awake Surgery Vs General Anesthesia to Guarantee Quick Access to Patients Who Needs Sinus Surgery

    Dec 1, 2023, 00:00

  • CO130 Q-TWiST Analysis Is Back in the Game in Oncology Clinical Trial Analysis: A Recent Trend

    Dec 1, 2023, 00:00

  • EE595 Cost-Effectiveness of HPV Catch-up Vaccination Program in Women Aged 13-24 Years in Low-and Middle- Income Country

    Dec 1, 2023, 00:00

  • HSD58 Real-World Prescribing of Long-Acting Injectable Cabotegravir for Treatment of HIV in the United States

    Dec 1, 2023, 00:00

  • HTA81 Exploring the Gap Between Regulatory Labels and Reimbursed Indications of Oncology Drugs in the Netherlands

    Dec 1, 2023, 00:00

  • MSR29 A Comparative Analysis of Missing Value Imputation Techniques: Parametric Imputation with eCDF (PIE) Vs Markov Chain Monte Carlo Imputation (MCMC)

    Dec 1, 2023, 00:00

  • EE601 Assessing the Barriers to Healthcare Resource Use (HRU) Data Collection and Offering Solutions to Support the Evidence Generation Process in LMICs

    Dec 1, 2023, 00:00

  • EPH126 Gender-Affirming Hormone Therapy and Psychological Distress Among Transgender and Nonbinary People: Differences by Source of Hormones

    Dec 1, 2023, 00:00

  • EPH114 Clinical Characteristics, Average Cost Per Visit, and Major Adverse Cardiovascular Events in Patients with Diagnosed Chronic Kidney Disease Combined with Cardiovascular Disease: A Study from a Large Healthcare Database in China

    Dec 1, 2023, 00:00

  • EE161 Economic Burden Associated with Stroke: A Comparative Analysis of Post-Stroke Care Costs

    Dec 1, 2023, 00:00

  • RWD76 Assessing the External Validity of Thin Database in Spain: A Reliable Source of Real-World Data for Observational Retrospective Research

    Dec 1, 2023, 00:00

  • PT14 Bayesian Meta-Analysis of Data From Trials of Mixed Patient Populations to Inform Health Economic Models for Patients Harboring a Predictive Biomarker

    Dec 1, 2023, 00:00

  • EE337 Cost-Effectiveness of Nirmatrelvir/Ritonavir in High-Risk Swedish Adults Including Post-Acute COVID Syndrome (PACS) From a Societal Perspective

    Dec 1, 2023, 00:00

  • PCR104 Is It Worth the Risk? Challenges and Recommendations for Devising Attributes and Levels for Safety-Related Attributes in Patient Preference Studies

    Dec 1, 2023, 00:00

  • PCR13 The Burden of Informal Caregivers of People Diagnosed With Myasthenia Gravis

    Dec 1, 2023, 00:00

  • EE175 Cost-Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada

    Dec 1, 2023, 00:00

  • EE528 Analysis of Non-Pharmacological Cost Savings Derived from the Use of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Breast Cancer in Spain

    Dec 1, 2023, 00:00

  • EPH197 An Integrated Modelling Methodology for Estimating Global, Regional, and Country-Specific Incidence and Prevalence of Tay-Sachs Disease at the Subtype Level

    Dec 1, 2023, 00:00

  • HPR208 Health Related Quality of Life Inequalities in Greece

    Dec 1, 2023, 00:00

  • HTA5 An Evaluation of the NICE Early Value Assessment: What Is the Opportunity for Digital Therapeutics?

    Dec 1, 2023, 00:00

  • EE291 Budget Impact Analysis of Mrna-1273 (Spikevax) in Patients with COVID-19 in Bulgaria

    Dec 1, 2023, 00:00

  • PT1 A Comparison of the UK and Australian Interim Value Sets for the Weight-Specific Adolescent Instrument for Economic Evaluation (WAItE)

    Dec 1, 2023, 00:00

  • HSD76 Assessing the Carbon Intensity Profile of an Immunization Program Against RSV in Infants in the United Kingdom to Show the Reduction in Emissions Versus Standard of Care

    Dec 1, 2023, 00:00

  • PT43 Cost-Effectiveness Analysis of Prostate-Specific Antigen (PSA)-Based Risk-Adapted Screening in Germany: An Early Economic Evaluation Study

    Dec 1, 2023, 00:00

  • MSR126 AutoCriteria: Advancing Clinical Trial Study With AI-Powered Eligibility Criteria Extraction

    Dec 1, 2023, 00:00

  • EPH177 The Impact of COVID-19 on National Mortality: Population-Based Interrupted Time Series Study in South Korea

    Dec 1, 2023, 00:00

  • SA32 Exploring the Feasibility of Indication-Based Pricing in the Korea Healthcare System: A Survey Study

    Dec 1, 2023, 00:00

  • HSD81 Automated Report Generation with Chat GPT API for Cardiology: Performance Evaluation and Impact on Physician Burnout

    Dec 1, 2023, 00:00

  • P4 Testing SimPy, a Library for Patient-Level Simulations in Python: An Application to Resource Management in Healthcare Systems

    Dec 1, 2023, 00:00

  • EE686 Cost Effectiveness of Ruxolitinib for Treatment of Steroid Refractory Acute Graft Versus Host Disease in Patients >12 Years of Age from a Singapore Healthcare System Perspective

    Dec 1, 2023, 00:00

  • CO78 Time to Diagnosis in Hypertrophic Cardiomyopathies and the Association With Adverse Outcomes Post-Diagnosis

    Dec 1, 2023, 00:00

  • HTA33 Are Digital Health Therapeutics Reshaping the HTA Framework for Health Technologies?

    Dec 1, 2023, 00:00

  • PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

    Dec 1, 2023, 00:00

  • HTA273 Managed Access Agreements in the UK: A Detailed Analysis of NICE's Utilization and Impact on Access

    Dec 1, 2023, 00:00

  • PCR197 Quality of Life and Duchenne Muscular Dystrophy: Greek Translation of the Pediatric Quality of Life Inventory (PEDSQL)3.0 Duchenne Muscular Dystrophy Module

    Dec 1, 2023, 00:00

  • PCR163 Modification of the Social Ecological Model to Distinguish the Terms “HRQoL” and “QoL” in Patient-Centered Outcomes Research

    Dec 1, 2023, 00:00

  • CO189 Comparative Efficacy of Voclosporin in Combination With Mycophenolate Mofetil Versus Other Treatments in Active Lupus Nephritis: Systematic Review and Network Meta-Analysis

    Dec 1, 2023, 00:00

  • EE212 Understanding Service Use for Melanoma in the UK National Health Servi An Expert Elicitation Exercise Using a New Method for Eliciting Proportions

    Dec 1, 2023, 00:00

  • PCR121 Insights, Needs, and Perspectives From Patients, Caregivers, and Healthcare Professionals on Shared Decision Making in Duchenne Muscular Dystrophy: A Qualitative Study

    Dec 1, 2023, 00:00

  • HTA232 A Multi-Criteria Decision Analysis Framework for the Value Assessment of First-Line Treatment of Adult Patients with Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • HSD106 Analysis of Health Economic Evidence in Clinical Practice Guidelines Published in China Between 2017 and 2022: An Investigative Study

    Dec 1, 2023, 00:00

  • PCR202 Atoderma: Clinical and Economic Burden of Moderate to Severe Atopic Dermatitis in the Czech Republic

    Dec 1, 2023, 00:00

  • PCR46 The Current Usage and Challenges of Goal Attainment Scaling in Clinical Settings

    Dec 1, 2023, 00:00

  • CO139 Acalabrutinib (AKA) Versus Venetoclax With Obinutuzumab (VEN+OBI) in Patients With Untreated Chronic Lymphocytic Leukemia (CLL) and Unmutated IGHV Genes – Indirect Comparison

    Dec 1, 2023, 00:00

  • HTA125 Assessment Outcome by HTA Agency Archetype: Five-Year Review for 20 European Countries

    Dec 1, 2023, 00:00

  • MSR87 How Many Simulations of a Dynamic Transmission Model Are Enough to Estimate Uncertainty?

    Dec 1, 2023, 00:00

  • EPH17 The Impact of COVID-19 Preventive Restrictions on the Development of Diseases of Despair: A Multi-Group Time Series Analysis

    Dec 1, 2023, 00:00

  • EE42 Comparison of Cost of Incident Rheumatoid Arthritis Patients in Turkey with Selected European Countries

    Dec 1, 2023, 00:00

  • EE541 Cost-Effectiveness, Health-State Utility Values (HSUVs) and Cost and Resource Use (CRU) Associated with Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS): An Economic Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • EPH33 Postpartum Hemorrhage: A Look into Colombia's Health System

    Dec 1, 2023, 00:00

  • MSR46 Breaking Through Limitations: Enhanced Systematic Literature Reviews With Large Language Models

    Dec 1, 2023, 00:00

  • EE599 Selection of Post-Patient Death Caregiver and Family Utilities When Estimating Spillover Effects

    Dec 1, 2023, 00:00

  • RWD119 A Decade of Alzheimer's Disease Management in Germany: The Increasing Impact of Specialists

    Dec 1, 2023, 00:00

  • CO188 Mortality and Clinical Complications Among Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in France

    Dec 1, 2023, 00:00

  • EE382 Burden and Economic Impact of Vaccine-Preventable Cancer Mortality in Europe

    Dec 1, 2023, 00:00

  • HPR117 Underinvestment in Poland and Its Impact on Health Outcomes

    Dec 1, 2023, 00:00

  • EE318 Cost-Effectiveness Analysis for Soliqua in the Treatment of T2DM in Turkiye

    Dec 1, 2023, 00:00

  • PCR3 EQ-5D Utilities for Patients With Nonalcoholic Steatohepatitis (NASH): A Comparison of Historical Utilities to a Recent Real-World Multi-Country Patient Survey

    Dec 1, 2023, 00:00

  • CO176 Treatment Approvals in Oncology and Relationship with Improvement in 5-Year Relative Survival for Cancer Patients in Europe

    Dec 1, 2023, 00:00

  • CO106 A Structured Expert Elicitation Exercise Conducted With UK Clinicians to Inform and Validate Inputs for a Cost-Effectiveness Analysis of FILSUVEZ® Gel (Birch Bark Extract) in Epidermolysis Bullosa

    Dec 1, 2023, 00:00

  • HTA84 Is Our Evidence Enough? A Review of G-BA's Ongoing Evidentiary Requirements in the Oncology Space

    Dec 1, 2023, 00:00

  • PCR17 The Development of a Comprehensive Archive of Patient-Reported Outcome Measures (PROMS) for Clinical Research and Clinical Practice in Oncology

    Dec 1, 2023, 00:00

  • HTA194 Do Health Technology Assessment (HTA) Bodies Recommend the Conduct and Submission of Artificial Intelligence-Based Literature Reviews (AILRS)?

    Dec 1, 2023, 00:00

  • EPH231 The Impact of COVID-19 on National Disease Dynamics: Population-Based Interrupted Time Series Study in South Korea

    Dec 1, 2023, 00:00

  • EPH267 A Quinquennial Review of the WHO’s Global Call for Action to Eliminate Cervical Cancer - an Indian Perspective

    Dec 1, 2023, 00:00

  • HTA272 EUnetHTA's HTA Core Model®: A Critical Assessment and Future Outlook

    Dec 1, 2023, 00:00

  • HTA101 Mapping Opportunities in the Access Landscape for a New Rare Disease Treatment Option in Multiple EU Countries

    Dec 1, 2023, 00:00

  • EE501 Impact of Eptinezumab on Healthcare Resource Utilization in Patients with Migraine in the United States: A Retrospective Cohort Claims Database Study

    Dec 1, 2023, 00:00

  • EE453 Projecting the Economic Benefits of the Elective Recovery Plan in England

    Dec 1, 2023, 00:00

  • P34 Health Technology Assessments of Digital Public Health Interventions in the Southeast Asia - A Systematic Scoping Review

    Dec 1, 2023, 00:00

  • EPH111 A Real-World Study of the Relationship between Lipoprotein(A) [Lp(A)] Concentrations and Atherosclerotic Cardiovascular Disease (ASCVD) Prognosis, Healthcare Resource Utilization and Medical Costs in Chinese Patients

    Dec 1, 2023, 00:00

  • HTA271 Shifting Landscape of Indirect Comparison Methodologies and Their Role in Informing NICE Decision-Making Processes

    Dec 1, 2023, 00:00

  • CO116 The Significance of Serum Transaminases As Predictors of Mortality in Paraquat Poisoning: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • CO58 Patient Characteristics and Treatment Patterns in Patients with Mantle Cell Lymphoma in Spain: A Real-World, Cross-Sectional Study

    Dec 1, 2023, 00:00

  • HTA233 Transportability of Overall Survival Estimates from US to UK Populations Receiving First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EE434 Analysis of the Clinical and Economic Impact of High Protein Concentration Ons in a Spanish Hospital Setting

    Dec 1, 2023, 00:00

  • HSD5 Knowledge, Attitude, and Practice of Pharmacy Professionals Against Dispensing Antibiotics Without Prescription in Ethiopia

    Dec 1, 2023, 00:00

  • HTA264 Baseline Natural History Models in Network Meta-Analysis: Guidance Versus Implementation in National Health and Care Excellence (NICE) Appraisals

    Dec 1, 2023, 00:00

  • PCR109 Patient Associations’ Members’ Perceptions of Level and Importance of Participation in Health Technology Assessment in Greece

    Dec 1, 2023, 00:00

  • RWD95 Eosinophilic Granulomatosis with Polyangiitis: Estimation of the Clinical and Economic Burden in Fran A Real-World Retrospective Study Based on the National Health Data System (SNDS)

    Dec 1, 2023, 00:00

  • HTA218 Public Engagement and Its Influence on Health Technology Assessment Outcomes in Latin America

    Dec 1, 2023, 00:00

  • EE460 Intraarterial Thrombectomy for Acute Ischemic Stroke: Cost-Effective or Dominant across All Age Groups in Brazil

    Dec 1, 2023, 00:00

  • HPR220 Assessment of the Relevance and Credibility of Indirect Treatment Comparisons (ITCs) to Help Inform Health Technology Assessment (HTA) and Reimbursement Decision-Making: Results of a 5-Country Payer Survey

    Dec 1, 2023, 00:00

  • EE623 Open Data Available in Fran A Great Asset to Study Real-Life Trends for Disease Burden - An Example With Bariatric Surgery Procedures

    Dec 1, 2023, 00:00

  • HTA296 Applying Continual Stakeholder Engagement to Develop Multi-Criteria Decision Analysis (MCDA) for Health Technology Assessment in Major Depressive Disorder (MDD)

    Dec 1, 2023, 00:00

  • HPR55 Reimbursement of High Priced One-Shot Treatments in Korea: KYMRIAH and ZOLGENSMA Case Study

    Dec 1, 2023, 00:00

  • RWD53 A Real-World Analysis of Treatment Patterns for First-Line Immunotherapies Among Danish Patients with Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression ≥50%

    Dec 1, 2023, 00:00

  • MSR99 Application of Artificial Intelligence in Literature Reviews

    Dec 1, 2023, 00:00

  • CO129 Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy (RWPC) for Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • EE577 Early Initiation of Guselkumab Increases Duration of Complete Remission (Psoriasis Area and Severity Index 100) in Patients With Moderate-to-Severe Psoriasis

    Dec 1, 2023, 00:00

  • EE492 Economic Analysis and Outcome Research on the Effectiveness of the Return to Work Program on Occupational Injury Cases for Workers with Disabilities

    Dec 1, 2023, 00:00

  • SA50 Economic Evaluation of Robotic-Assisted Surgery: Methods, Challenges, and Opportunities

    Dec 1, 2023, 00:00

  • HTA305 Multicriteria Decision Analysis (MCDA) to Elicit Criteria for CAR-T Cell Health Technology Assessment (HTA) in Brazilian Private Healthcare System

    Dec 1, 2023, 00:00

  • PT47 High-Volume Hospitals Experience Fewer Postoperative Complications After Neonatal Surgery: Analyses of the National Clinical Database Pediatric Surgical Registry in Japan

    Dec 1, 2023, 00:00

  • EE761 The Impact of Differences in Patient Demographics on Assessment of Long-Term Cost-Effectiveness in Cohort Level Economic Models

    Dec 1, 2023, 00:00

  • EPH151 Prevalence of Risk Factors for Serious Adverse Events Among Rheumatoid Arthritis Patients Prescribed Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors: A Merative Marketscan Cross-Sectional Study

    Dec 1, 2023, 00:00

  • RWD160 Time to Treatment Initiation and Patient Characteristics in Newly Diagnosed Multiple Myeloma Patients With and Without Transplant: Real-World Evidence Using Big Data From England

    Dec 1, 2023, 00:00

  • CO115 The Interpretation and Grading of Evidence Derived From Interim Analyses for the Assessment of the Pharmacotherapeutic Efficacy of Medicines

    Dec 1, 2023, 00:00

  • EE160 Healthcare Expenditure for Treatment of Hypertension and Hypertensive Complications in Japan: A Claims Data Analysis

    Dec 1, 2023, 00:00

  • EPH8 Insulin Analogs in Type 1 Diabetes Treatment: An Incorporation Process Study in Brazilian Unified Health System (SUS)

    Dec 1, 2023, 00:00

  • EE313 Cost-Utility of Apixaban for Secondary Stroke Prevention in Brazil

    Dec 1, 2023, 00:00

  • HPR68 Comprehensive Genomic Profiling Approaches in Europe and the US: A Review of Guidelines and Recommendations for Solid Tumors

    Dec 1, 2023, 00:00

  • HTA153 Did OS Immaturity Preclude from Receiving a Positive Recommendation: Review of Recent Oncology NICE/TA?

    Dec 1, 2023, 00:00

  • EPH68 What Are the Main Symptoms of Long COVID? Real World Medical Data Cross-Referenced with Social Network Content

    Dec 1, 2023, 00:00

  • HPR159 Emerging Trends Shaping the Healthcare Ecosystem in the Middle East and North Africa Region

    Dec 1, 2023, 00:00

  • RWD45 Describing Medication Switching Patterns Among Adults With Rheumatoid Arthritis From 2016-2022 Using Real-World Data

    Dec 1, 2023, 00:00

  • EE74 Cost-Effectiveness Analysis of LUNGFLAGTM Risk Prediction Model in the Selection of Individuals for Lung Cancer Screening in Spain

    Dec 1, 2023, 00:00

  • RWD24 Decision Making and the Questions Raised When Real World Evidence From a Federated Data Network Conflicts With RCT Data: A Use Case on COVID-19 Treatments

    Dec 1, 2023, 00:00

  • EE706 Impact of Valoctocogene Roxaparvovec on the Economic Burden of Adults with Severe Hemophilia A Managed with Prophylaxis in the United States

    Dec 1, 2023, 00:00

  • CO61 Isatuximab in Multiple Myeloma: Safety and Effectiveness

    Dec 1, 2023, 00:00

  • PCR255 Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions

    Dec 1, 2023, 00:00

  • EPH72 Polysubstance Use of Psychoactive Stimulants, Suicidal Behavior, and Mental Health Disability Among Women of Reproductive Age

    Dec 1, 2023, 00:00

  • CO40 Non-Communicable Diseases Prevention in India: A Review of Suitable Instruments for Surveillance and a General Overview of Cultural, Behavioral Practices and Risk Factors for the Adult Population

    Dec 1, 2023, 00:00

  • EE137 Healthcare Resource Utilization and Estimated Costs in Adult Pneumococcal Disease in Peru: Results from a Panel of Experts

    Dec 1, 2023, 00:00

  • EE737 Cost-Effectiveness Models of Continuous Glucose Monitoring in Individuals With Type 1 Diabetes: A Systematic Review on Methodology and Quality

    Dec 1, 2023, 00:00

  • PCR203 A Qualitative Study of the Health-Related Quality of Life Impact of Geographic Atrophy on Patients

    Dec 1, 2023, 00:00

  • HTA28 The Use of Expert Opinions, Patient, and Carer Perspectives and Real-World Evidence in Orphan Disease Submissions Differs for Health Technology Assessment Agencies Across the World

    Dec 1, 2023, 00:00

  • HTA132 Reporting Patient Preference Studies in Health Technology Assessment Submissions: Does It Make a Difference?

    Dec 1, 2023, 00:00

  • CO38 Real-World Comparative COVID-19 Vaccine Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 Among Immunocompromised Adults in the US

    Dec 1, 2023, 00:00

  • CO174 Real World Data of Daratumumab Treatment in Patient with Multiple Myeloma: A Portuguese Study

    Dec 1, 2023, 00:00

  • MT38 Identifying High Cost and High Mortality Genetic Disease in the NICU

    Dec 1, 2023, 00:00

  • MSR108 Geographic Search Filters for Embase.Com Interfa An Analysis Utilizing Multiple Case Studies

    Dec 1, 2023, 00:00

  • HPR188 Orphan Drugs – How Will the New Proposed European Union (EU) Commission Pharmaceutical Regulation Impact Therapies for Rare Diseases?

    Dec 1, 2023, 00:00

  • EPH142 Fibrodysplasia Ossificans Progressiva (FOP): Prevalence Estimate By Hospitalization Data

    Dec 1, 2023, 00:00

  • EE641 Socioeconomic Status and Economic Burden of Pertussis in Adults: Post-Hoc Analyses of a Retrospective Database Study in England

    Dec 1, 2023, 00:00

  • MSR44 Inflation, the Usual Suspect: Are Oncology Drugs Really Victims of the Macroeconomic Context?

    Dec 1, 2023, 00:00

  • HPR167 Neutralizing Efficacy of Expired Snake Antivenoms: A Systematic Review of Preclinical Studies and Real-World Experience

    Dec 1, 2023, 00:00

  • EE189 Combining Causal Inference and Within-Trial Economic Evaluation Methods to Assess the Cost-Effectiveness of a Mental Health Service Using Real-World Data: The Quasi-Experimental Adapt Study

    Dec 1, 2023, 00:00

  • HTA96 Carer Burden: Is HTA Helping or Harming the Gender Health Gap?

    Dec 1, 2023, 00:00

  • MSR6 Application of the Atlas Algorithm to Identify the Carboplatin+Gemcitabine Regimen in Patients with Metastatic Triple-Negative Breast Cancer (MTNBC) through the French Nationwide Hospital Discharge Database (PMSI)

    Dec 1, 2023, 00:00

  • EPH213 Hepatitis B Virus (HBV) and Human Papilloma Virus (HPV) Related Cancers Elimination Impact on Treatment Patterns (HELP-France) in France

    Dec 1, 2023, 00:00

  • EE278 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United Kingdom

    Dec 1, 2023, 00:00

  • SA69 Impact of COVID-19 on Health Care Resource Utilization and Costs in Patients With Chronic Obstructive Pulmonary Disease and Asthma in the United States (2018–2022): A Population-Based Study

    Dec 1, 2023, 00:00

  • EE654 Occupational Impact of Tardive Dyskinesia: A Cross-Sectional, International Survey Assessing the Perceptions and Experiences of Patients With TD and Physicians Who Treat TD

    Dec 1, 2023, 00:00

  • PCR26 Testing the Psychometric Properties of Several Euroqol Instruments for Measuring the Impact of COVID-19 in a Large Sample of Chinese Children and Their Parent Carers

    Dec 1, 2023, 00:00

  • HTA121 The Triple Bottom Line in Healthcare: A Holistic Sustainability Assessment for Decision Support

    Dec 1, 2023, 00:00

  • HTA3 Health Technology Assessment Requirements: Sensitive to Bacteriophage Products or Too Resistant to Change?

    Dec 1, 2023, 00:00

  • EE633 Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease

    Dec 1, 2023, 00:00

  • PCR42 Humanistic Burden of Paroxysmal Nocturnal Hemoglobinuria from the Patient Perspective: Results from a Cross-Sectional Study

    Dec 1, 2023, 00:00

  • EPH108 Quality of Life of Menopausal Women

    Dec 1, 2023, 00:00

  • EE722 Cost-Utility Analysis for Haemate-P in the Treatment of Von Willebrand Disease

    Dec 1, 2023, 00:00

  • RWD152 Describing the Management of Spondyloarthropathies in French Primary Care: An EHR Study Exploring Regional Differences

    Dec 1, 2023, 00:00

  • OP28 Are Best Practice Methods for Expert Elicitation Being Applied in NICE Highly Specialized Technology (HST) Submissions? A Review and Evaluation

    Dec 1, 2023, 00:00

  • HSD19 Evaluation of Vascular Access Modality for Hemodialysis Patients: Analysis of Real-World Data in Italy

    Dec 1, 2023, 00:00

  • PCR82 Hierarchical Clustering of Rare Diseases Based on Functional Impacts to Support the Identification of Potential Patient-Centered Outcomes Measures for Rare Diseases Research

    Dec 1, 2023, 00:00
  • «
  • 11
  • 12
  • 13
  • 14 (current)
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »